Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen-Bin Lv

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Medicine|December 22, 2019
Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junctionMing-Zhi Cai, Chen-Bin Lv, Li-Sheng Cai, et al.
Frontiers in Oncology|December 15, 2025
Beneficial impact of indocyanine green fluorescence imaging on lymphadenectomy in laparoscopic total gastrectomy for advanced upper gastric cancerChen-Bin Lv, Lin-Yan Tong, Yu-Qin Sun, et al.
World Journal of Surgical Oncology|September 10, 2024
Efficacy of neoadjuvant chemotherapy combined with prophylactic intraperitoneal hyperthermic chemotherapy for patients diagnosed with clinical T4 gastric cancer who underwent laparoscopic radical gastrectomy: a retrospective cohort study based on propensity score matchingChen-Bin Lv, Lin-Yan Tong, Wei-Ming Zeng, et al.
BMC Cancer|September 28, 2024
Impact of dynamic changes of tumor marker in neoadjuvant chemotherapy-treated triple-negative gastric cancer patients: a multi-center studyHua-Long Zheng, Ling-Kang Zhang, Chen-Bin Lv, et al.
Iscience|April 30, 2026
Dynamic systemic immune-inflammation index predicts survival after neoadjuvant immunotherapy in gastric cancer: A multicenter studyHua-Long Zheng, Li-Li Shen, Chen-Bin Lv, et al.
Surgical Endoscopy|December 17, 2016
Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control studyChang-Ming Huang, Chen-Bin Lv, Jian-Xian Lin, et al.
Medicine|May 27, 2016
Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database AnalysisChen-Bin Lv, Chang-Ming Huang, Chao-Hui Zheng, et al.
Annals of Medicine|May 7, 2025
Timing of postoperative chemotherapy and prognosis in neoadjuvant-treated gastric cancer patients: a multicenter real-world cohort studyHua-Long Zheng, Ling-Kang Zhang, Hong-Hong Zheng, et al.
World Journal of Gastrointestinal Surgery|June 30, 2025
Efficacy and safety of sintilimab combined with nab-paclitaxel plus S-1 for neoadjuvant treatment of locally advanced gastric cancerQiu-Xian Chen, Yong-Bin Zhang, Wei-Ming Zeng, et al.
Journal of Gastrointestinal Cancer|January 4, 2024
Development and Validation of a Prognostic Model for Postoperative Anastomotic Recurrence in Siewert II or III Adenocarcinomas Without Neoadjuvant Therapy in an East Asian PopulationMing-Bin Huang, Chao Xu, Hong Chen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Medicine|December 22, 2019
Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junctionMing-Zhi Cai, Chen-Bin Lv, Li-Sheng Cai, et al.
Frontiers in Oncology|December 15, 2025
Beneficial impact of indocyanine green fluorescence imaging on lymphadenectomy in laparoscopic total gastrectomy for advanced upper gastric cancerChen-Bin Lv, Lin-Yan Tong, Yu-Qin Sun, et al.
World Journal of Surgical Oncology|September 10, 2024
Efficacy of neoadjuvant chemotherapy combined with prophylactic intraperitoneal hyperthermic chemotherapy for patients diagnosed with clinical T4 gastric cancer who underwent laparoscopic radical gastrectomy: a retrospective cohort study based on propensity score matchingChen-Bin Lv, Lin-Yan Tong, Wei-Ming Zeng, et al.
BMC Cancer|September 28, 2024
Impact of dynamic changes of tumor marker in neoadjuvant chemotherapy-treated triple-negative gastric cancer patients: a multi-center studyHua-Long Zheng, Ling-Kang Zhang, Chen-Bin Lv, et al.
Iscience|April 30, 2026
Dynamic systemic immune-inflammation index predicts survival after neoadjuvant immunotherapy in gastric cancer: A multicenter studyHua-Long Zheng, Li-Li Shen, Chen-Bin Lv, et al.
Surgical Endoscopy|December 17, 2016
Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control studyChang-Ming Huang, Chen-Bin Lv, Jian-Xian Lin, et al.
Medicine|May 27, 2016
Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database AnalysisChen-Bin Lv, Chang-Ming Huang, Chao-Hui Zheng, et al.
Annals of Medicine|May 7, 2025
Timing of postoperative chemotherapy and prognosis in neoadjuvant-treated gastric cancer patients: a multicenter real-world cohort studyHua-Long Zheng, Ling-Kang Zhang, Hong-Hong Zheng, et al.
World Journal of Gastrointestinal Surgery|June 30, 2025
Efficacy and safety of sintilimab combined with nab-paclitaxel plus S-1 for neoadjuvant treatment of locally advanced gastric cancerQiu-Xian Chen, Yong-Bin Zhang, Wei-Ming Zeng, et al.
Journal of Gastrointestinal Cancer|January 4, 2024
Development and Validation of a Prognostic Model for Postoperative Anastomotic Recurrence in Siewert II or III Adenocarcinomas Without Neoadjuvant Therapy in an East Asian PopulationMing-Bin Huang, Chao Xu, Hong Chen, et al.
Pageof 2